EUVIMEDEUVIMED entdecken
Crossref

Systems Biology, Multi-Omics, and Artificial Intelligence Paradigms in Bacterial Mutational Resistance and De Novo Antibacterial Drug Design

Monochura Saha, Miss Smriti, Priyanka Kumari

Advances in Medical Sciences and Research · 13.07.2026 · 1 (3) · 179-203

DOI: 10.55578/amsr.2607.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences and Research, online erschienen am 13.07.2026. Verfasst von Monochura Saha und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) represents one of the most critical global threats to public health; it was associated with an estimated 4.95 million deaths in 2019 [1] and is projected to claim up to 10 million lives annually by 2050 if no effective interventions are implemented [2]. The rapid dissemination of multidrug-resistant (MDR) bacterial strains continues to render first-line and last-resort antibiotics ineffective, outpacing traditional drug discovery pipelines. The rapid dissemination of multidrug-resistant (MDR) bacterial strains continues to render first-line and last-resort antibiotics ineffective, outpacing traditional drug discovery pipelines [3]. Historically, the development of new antibacterial agents relied on modifying existing chemical classes, a strategy that is increasingly vulnerable to rapid selection of resistance under clinical pressure [4]. To overcome this bottleneck, the modern research paradigm is shifting from single-molecule investigations to systems-level analyses [5]. The convergence of high-throughput multi-omics profiling spanning genomics, transcriptomics, proteomics, and metabolomics with advanced artificial intelligence (AI) and machine learning (ML) architectures offers a powerful framework for deciphering the complex molecular underpinnings of resistance and accelerating target-directed drug discovery [6].

Zitieren

APA

Saha, M., Smriti, M., & Kumari, P. (2026). Systems Biology, Multi-Omics, and Artificial Intelligence Paradigms in Bacterial Mutational Resistance and De Novo Antibacterial Drug Design. Advances in Medical Sciences and Research, 1(3), 179-203. https://doi.org/10.55578/amsr.2607.012

Vancouver

Saha M, Smriti M, Kumari P. Systems Biology, Multi-Omics, and Artificial Intelligence Paradigms in Bacterial Mutational Resistance and De Novo Antibacterial Drug Design. Advances in Medical Sciences and Research. 2026;1(3):179-203. doi:10.55578/amsr.2607.012

BibTeX
@article{Saha2026,
  author = {Saha, Monochura and Smriti, Miss and Kumari, Priyanka},
  title = {Systems Biology, Multi-Omics, and Artificial Intelligence Paradigms in Bacterial Mutational Resistance and De Novo Antibacterial Drug Design},
  journal = {Advances in Medical Sciences and Research},
  year = {2026},
  volume = {1},
  number = {3},
  pages = {179--203},
  doi = {10.55578/amsr.2607.012}
}
Kostenlos starten →